![Harry Trout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 238 354 $ al 30/06/2026
Mr. Harry R.
Trout is a Chief Financial Officer at Enanta Pharmaceuticals, Inc. He received his undergraduate degree from Massachusetts College of Liberal Arts and an MBA from Southern New Hampshire University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/12/2025 | 16.348 ( 0,06 % ) | 238 354 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Director Financiero/CFO | 26/08/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Massachusetts College of Liberal Arts
 Massachusetts College of Liberal Arts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern New Hampshire University
 Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
